Mantle cell lymphoma (MCL) is a B-cell malignancy with an inferior prognosis in comparison to other lymphomas. Most patients present …
Developing Hematology is a blog written for medical professionals who practice clinical hematology in developing countries
We aim to offer a practical insight, from the perspective of scientists working in low to middle-income countries, where most of the population of the entire world are actually living in.
Free from the shackles of formality which limit our written word to rigid scientific language in peer reviewed medical journals, this space offers sincere opinions from a variety of editorialists on current clinical hematology research.
With a focus on issues regarding resource optimization, diagnostic strategies and treatment availability, Developing Hematology hopes to become a useful reference for all professionals working in a restricted environment.
Mantle cell lymphoma (MCL) is a B-cell malignancy with an inferior prognosis in comparison to other lymphomas. Most patients present …
Chronic graft versus host disease (cGVHD) is the major factor limiting quality of life for allogeneic transplant recipients who have …
Around 80% of children with ITP are disease-free within 1 year; a watch and wait strategy is considered standard for …